Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,935 | 230 | 96.8% |
| Education | $163.99 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,719 | 87 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $563.31 | 24 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $557.63 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $350.95 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $322.17 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $205.65 | 11 | $0 (2023) |
| PFIZER INC. | $175.25 | 9 | $0 (2024) |
| Lilly USA, LLC | $151.80 | 10 | $0 (2024) |
| CSL Behring | $141.49 | 2 | $0 (2020) |
| Intercept Pharmaceuticals, Inc. | $127.61 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,087 | 101 | ABBVIE INC. ($615.42) |
| 2023 | $1,121 | 47 | Regeneron Healthcare Solutions, Inc. ($220.20) |
| 2022 | $802.29 | 34 | ABBVIE INC. ($367.03) |
| 2021 | $820.97 | 42 | AbbVie Inc. ($456.82) |
| 2020 | $142.16 | 7 | AbbVie Inc. ($93.14) |
| 2018 | $124.84 | 1 | CSL Behring ($124.84) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $1.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/31/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: LIVER DISEASE | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Immunology | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 351 | 431 | $95,285 | $42,000 |
| 2022 | 8 | 361 | 518 | $113,385 | $44,410 |
| 2021 | 8 | 396 | 547 | $112,805 | $50,912 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 98 | $23,770 | $13,438 | 56.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 111 | $13,395 | $7,139 | 53.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 57 | $12,735 | $5,671 | 44.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $16,720 | $4,753 | 28.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $4,950 | $2,755 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 20 | $2,700 | $2,032 | 75.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $6,800 | $1,826 | 26.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 24 | 24 | $4,800 | $1,567 | 32.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 35 | $2,275 | $1,426 | 62.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $7,140 | $1,392 | 19.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 97 | 175 | $39,375 | $15,156 | 38.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 93 | 172 | $30,100 | $10,134 | 33.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 43 | $13,115 | $7,239 | 55.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $8,450 | $3,633 | 43.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 47 | 47 | $9,400 | $2,843 | 30.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $4,950 | $2,546 | 51.4% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 21 | 21 | $5,775 | $2,163 | 37.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $2,220 | $696.75 | 31.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 97 | 175 | $33,825 | $15,553 | 46.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 67 | 67 | $20,435 | $11,300 | 55.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 84 | 154 | $24,225 | $9,352 | 38.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 27 | 29 | $9,425 | $4,340 | 46.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 32 | 32 | $7,200 | $3,682 | 51.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 55 | 55 | $9,150 | $3,409 | 37.3% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 23 | 23 | $6,325 | $2,550 | 40.3% |
About Colin Leffert
Colin Leffert is a Internal Medicine healthcare provider based in Lakewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2017. The National Provider Identifier (NPI) number assigned to this provider is 1881127140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Colin Leffert has received a total of $5,099 in payments from pharmaceutical and medical device companies, with $2,087 received in 2024. These payments were reported across 232 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,935).
As a Medicare-enrolled provider, Leffert has provided services to 1,108 Medicare beneficiaries, totaling 1,496 services with total Medicare billing of $137,323. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Gastroenterology
- Location Lakewood, CO
- Active Since 04/04/2017
- Last Updated 12/18/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881127140
Products in Payments
- MAVYRET (Drug) $651.43
- XIFAXAN (Drug) $508.34
- RINVOQ (Biological) $495.74
- ENTYVIO (Biological) $422.41
- DUPIXENT (Biological) $311.63
- STELARA (Biological) $260.50
- LINZESS (Drug) $197.58
- XELJANZ (Drug) $175.25
- SKYRIZI (Biological) $160.61
- HUMIRA (Biological) $143.62
- OMVOH (Drug) $137.96
- OCALIVA (Drug) $127.61
- Berinert (Biological) $124.84
- IBSRELA (Drug) $120.58
- ZEPOSIA (Drug) $108.48
- EOHILIA (Drug) $95.07
- TREMFYA (Drug) $90.45
- DIFICID (Drug) $86.11
- CREON (Drug) $69.64
- TRULANCE (Drug) $54.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lakewood
William Bensinger, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Howard Uderman, M.d, M.D
Internal Medicine — Payments: $947,366
Dr. Kenneth Cohen, M.d, M.D
Internal Medicine — Payments: $269,079
Omkar Marathe, Md, MD
Internal Medicine — Payments: $41,508
Joseph Morelos, D.o, D.O
Internal Medicine — Payments: $32,524
Sarah Easaw, Md Llc, MD LLC
Internal Medicine — Payments: $28,719